Man-Gi Joo
Yonsei University · Medicine
About the Lab
Professor Man-Gi Joo's research lab specializes in transplant medicine and patient-centered healthcare, with a strong focus on improving long-term outcomes for organ transplant recipients. Key research directions include enhancing treatment adherence and self-management through health literacy, patient motivation, and tailored education programs. The lab also investigates post-transplant complications such as malignancy and graft survival, emphasizing predictive biomarkers like early post-transplant serum creatinine levels. Additionally, the lab contributes to oncology research, particularly in evaluating targeted therapies for advanced colorectal cancer.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
15Findings indicate that the video education materials will meet the needs of adult learners and mitigate the limitations of the existing education programs by increasing interest and motivation and may contribute to increased treatment adherence and ultimately, positively effect self-care for new transplant patients.
The incidence of malignancy in transplant recipients is known to be higher than the same in the general population. However, the types of malignancies vary geographically, and the relative risks (RR) for malignancy in transplant recipients, compared with that of the general population, also differ country-by-country. In this study, we investigated the incidence and characteristics of malignancies after renal transplantation in a single center. A total of 2630 renal recipients who underwent surge
This study was conducted to determine the correlations between health literacy, transplant effects, and compliance to treatment in organ transplant recipients and to identify the factors influencing compliance to treatment. The participants (n = 130; males = 66.9%; mean age = 56.4 years) were organ transplant recipients visiting an organ transplantation center in Seoul, South Korea. The regression model explained 32% of the variance in participants’ compliance to treatment. Among the health lite
BACKGROUND: vascular endothelial growth factor receptor 2 (VEGFR-2) has an important role in colorectal cancer pathogenesis and progression. The aim of our study is to provide a protocol for assessing the efficacy and safety of ramucirumab (a monoclonal antibody VEGFR-2 antagonist) for the treatment of advanced colorectal cancer. METHODS: The systematic review will be reported according to the preferred reporting items for systematic reviews and meta-analyses protocols. Relevant randomized contr
Serum creatinine level at 1-month posttransplant is a strong independent predictor of graft survival and functional graft status beyond ten years posttransplant.
Research Areas
Dive deeper into Man-Gi Joo's research on Nubint
Open this lab's papers in the app to read with AI, summarize, and cite in your writing.